The global endoscopic ultrasound market was valued at USD 830.6 million in 2018 and is anticipated to reach USD 2,023.6 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.6% over the forecast period from 2018 to 2032. In 2018, North America held the largest market share, accounting for 35.75% of the global market.

The endoscopic ultrasound market is witnessing significant growth, driven by the increasing prevalence of gastrointestinal, pancreatic, and lung disorders, along with the rising demand for minimally invasive diagnostic procedures. Endoscopic ultrasound (EUS) combines endoscopy and ultrasound technologies to obtain high-resolution images and tissue samples from within the body, enabling early detection and accurate staging of various cancers. Technological advancements, including enhanced imaging capabilities and the integration of fine-needle aspiration, have expanded the clinical applications of EUS. Additionally, growing awareness about early diagnosis, coupled with improvements in healthcare infrastructure, especially in emerging economies, is expected to further propel the growth of the endoscopic ultrasound market in the coming years.

Continue reading for more details:

https://www.fortunebusinessinsights.com/industry-reports/endoscopy-ultrasound-market-100558

Market Segmentation

• The endoscopic ultrasound market is segmented by product into endoscopes, ultrasound probes, processors, needles, and accessories.

• By application, the market includes oncology, gastroenterology, pulmonology, and others, with oncology holding a significant share.

• Based on end user, the endoscopic ultrasound market is divided into hospitals, specialty clinics, and ambulatory surgical centers.

• The market is also categorized by procedure type, including upper endoscopy, lower endoscopy, and combined procedures.

List of Key Companies Covered:

• Olympus Corporation

• PENTAX Medical

• FUJIFILM Holdings Corporation

• Cook Medical

• Boston Scientific Corporation

• Medtronic

• Medi-Globe GmbH

• CONMED Corporation

Market Growth

• The endoscopic ultrasound market is experiencing robust growth due to the rising prevalence of gastrointestinal disorders and increased demand for minimally invasive diagnostic procedures.

• Technological advancements in imaging quality and integration with fine-needle aspiration systems are further propelling the endoscopic ultrasound market.

• Growing awareness about early cancer detection is driving adoption of endoscopic ultrasound across healthcare facilities.

• The increasing use of endoscopic ultrasound in both diagnostic and therapeutic procedures supports consistent growth in the endoscopic ultrasound market.

Restraining Factors

• High costs associated with endoscopic ultrasound equipment and procedures can limit adoption, especially in resource-limited settings.

• Lack of skilled professionals to perform and interpret endoscopic ultrasound procedures is a major challenge for the endoscopic ultrasound market.

• Reimbursement limitations and regulatory hurdles may impact market expansion in certain regions.

• Limited access to advanced healthcare technologies in underdeveloped areas restrains the growth of the endoscopic ultrasound market.

Regional Analysis

• North America dominates the endoscopic ultrasound market due to advanced healthcare infrastructure, high procedure volumes, and strong adoption of new technologies.

• Europe follows closely, supported by favorable reimbursement policies and growing awareness of early cancer diagnostics.

• The Asia-Pacific region is emerging as a high-growth area in the endoscopic ultrasound market, driven by increasing investments in healthcare and rising disease burden.

• Latin America and the Middle East & Africa are gradually expanding in the endoscopic ultrasound market due to improving healthcare access and growing demand for diagnostic services.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road,

Baner, Pune-411045, Maharashtra, India.

Phone: U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com